CLINICAL EXPERIENCE WITH THE USE OF R48 (NN-DI-2′-CHLOROETHYL-2′-NAPHTHYLAMINE)
- 1 April 1958
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 68 (3) , 1116-1121
- https://doi.org/10.1111/j.1749-6632.1958.tb42672.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Multiple Myelomatosis Treated with a Combination of Urethane and an Oral Nitrogen MustardBlood, 1955
- Oral Treatment of Polycythaemia Vera with -Naphthyl-di-2-ChloroethylamineBMJ, 1951
- TRIAL OF β-NAPHTHYL-DI-2-CHLOROETHYLAMINE IN LEUKÆMIA, HODGKIN'S DISEASE, AND ALLIED DISORDERSThe Lancet, 1951
- A TRIAL OF $beta;-NAPHTHYLDI-2-CHLOROETHYLAMINE (R48) IN LEUKqMIA, HODGKIN'S DISEASE, AND ALLIED DISEASESThe Lancet, 1950
- 420. Aryl-2-halogenoalkylamines. Part IIJournal of the Chemical Society, 1949
- 43. Aryl-2-halogenoalkylamines. Part IJournal of the Chemical Society, 1949
- Effects upon tumours of Various HaloalkylarylaminesNature, 1948